TOPAbout TaihoGlobalization

Globalization

Becoming a Truly Global Specialty Pharma
That Meets the Expectations of Patients Worldwide

Having amassed a significant body of clinical evidence in the field of oncology, Taiho Pharmaceutical has contributed to the establishment of better treatment methods for years now as Japan's pioneer in developing oral anticancer agents. Since the start of the new millennium, Taiho Pharmaceutical has made every effort to increase its global reach, seeking to bring smiles to the faces of more patients around the world. The company is pursuing global R&D while building its own sales structure in the U.S. and expanding its sales network in other countries.

*Click the "Click!" icons to view larger images.

Click this images to see a larger version. Click this images to see a larger version. Click this images to see a larger version. Click this images to see a larger version. Click this images to see a larger version.

New Global Leaders Training Program Planned for 2016

In July 2016, Taiho Pharmaceutical will be launching Global One Academy, a corporate university which will be focusing on corporate culture, philosophy and history, while also recognizing the importance of training students to become leaders with global perspective, creativity and a spirit that embraces challenges.

TAIHO ONCOLOGY

Taiho Pharmaceutical created the TAIHO ONCOLOGY brand to leverage its Japanese reputation worldwide, seeking to increase its global market recognition as a leader in the field of oncology. The company is promoting the brand at academic conferences, pursuing open innovation based on cooperation with farsighted medical professionals and researchers. The TAIHO ONCOLOGY brand stands for the determination to create cancer treatments that will more quickly and more definitely become global standards, for the benefit of patients worldwide.


Top of Page